<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03180125</url>
  </required_header>
  <id_info>
    <org_study_id>Hyaluronic injection</org_study_id>
    <nct_id>NCT03180125</nct_id>
  </id_info>
  <brief_title>Hyaluronic Acid Hydro-dissection Use in Idiopathic Carpal Tunnel Syndrome Guided by Ultrasonic Study</brief_title>
  <official_title>Use of Hyaluronic Acid Injection in Treatment of Idiopathic Carpal Tunnel Syndrome Versus Corticosteroid Injection Sonographically Guided</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      carpal tunnel syndrome (CTS) is the most common compression syndrome in the upper
      extremities, CTS is characterized by typical anatomic changes, the most probable swelling of
      the median nerve in the proximal part of the CT.

      Local infiltration of corticosteroids easily leads to atrophy of the median nerve,
      subcutaneous fat, and systematic complications, surgical treatment decision is always taken
      by the patient who sometimes wants to delay or avoid the surgery because of psychological or
      medical concerns, It would be interesting if low molecular weight sodium hyaluorinate
      injection is used as an alternative conservative treatment of CTS. This study aims to
      investigate if, and to what extent, hydro-dissection using 1% lidocain followed by injection
      of Sodium hyaluronate versus 1% lidocain followed by injection of 40 mg of triamcinolone
      acetonide, under ultrasound guidance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 CT patients, blindly divided into two groups. Both will underwent median nerve
      hydro-dissection using 1% lidocain followed by group I injection of Sodium hyaluronate and
      group II injection of 40 mg of triamcinolone acetonide, under ultrasound guidance. Baseline
      VAS pain and nerve conduction study, patient satisfaction, and therapeutic duration, will be
      determined in 2nd week, 3rd and 6th month after the procedure. US measurements of the median
      nerve cross-sectional area (CSA) in the CT inlet will be compared pre and post procedure in
      6th month and use NCS results as the gold standard diagnostic test.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Actual">October 1, 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>neuropathic pain VAS</measure>
    <time_frame>2 weeks</time_frame>
    <description>0-10 VAS scale in the 2nd week after injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>nerve conduction study</measure>
    <time_frame>1 month</time_frame>
    <description>motor nerve conduction</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1month</time_frame>
    <description>(Likert scale) with the grade 1 means that the patient's satisfaction was 30% ,grade 2, the patient's satisfaction was 30-50%,grade 3 ,the satisfaction was 50-80% ,and grade 4 was 80%, Grades 3 and 4 were defined as &quot;overall satisfied</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>sodium hyaluorinate ultrasound guided</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>median nerve hydro-dissection using 1% lidocain followed by low molecular weight sodium hyaluronate (Hyalgan) injection ultrasonographically guided</description>
  </arm_group>
  <arm_group>
    <arm_group_label>corticosteroid with ultrasound guided</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>median nerve hydro-dissection using 1% lidocain followed by injection of corticosteroid Ultrasonographically guided</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Hyaluronate</intervention_name>
    <description>median nerve in CTS hydro-dissection using 1% lidocain followed by injection of Sodium hyaluronate guided by ultrasound</description>
    <arm_group_label>sodium hyaluorinate ultrasound guided</arm_group_label>
    <other_name>hyalgan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrasound</intervention_name>
    <description>ultrasound guided injection</description>
    <arm_group_label>sodium hyaluorinate ultrasound guided</arm_group_label>
    <arm_group_label>corticosteroid with ultrasound guided</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Hyaluronate and 1% lidocain</intervention_name>
    <description>injection in the carpal tunnel</description>
    <arm_group_label>sodium hyaluorinate ultrasound guided</arm_group_label>
    <arm_group_label>corticosteroid with ultrasound guided</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid and 1%lidocain</intervention_name>
    <description>injection in the carpal tunnel</description>
    <arm_group_label>corticosteroid with ultrasound guided</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with mild or moderate carpal tunnel diagnosed by nerve conduction study

        Exclusion Criteria:

          -  secondary carpal tunnel to any other disease and peripheral neuropathy patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>manal hassanien, MD</last_name>
    <phone>01062679200</phone>
    <email>&lt;manal_hassanien@yahoo.com&gt;</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut governorate</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>manal hassanien, MD</last_name>
      <phone>01062679200</phone>
      <email>&lt;manal_hassanien@yahoo.com&gt;</email>
    </contact>
    <contact_backup>
      <last_name>ghada abo elfadl, MD</last_name>
      <phone>01005802086</phone>
      <email>ghadafadl77@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Manal Hassanien</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>hydrodissection</keyword>
  <keyword>sodium hyaluorinate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

